Messages for Clinicians: Moderators and Mediators of Treatment Outcome in Randomized Clinical Trials

被引:88
|
作者
Kraemer, Helena Chmura [1 ]
机构
[1] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2016年 / 173卷 / 07期
关键词
PSYCHOLOGICAL-RESEARCH; PUBLISHED RESEARCH; EFFECT SIZE; CRITERIA; RATHER; RISKS;
D O I
10.1176/appi.ajp.2016.15101333
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Many problems in randomized clinical trial design, execution, analysis, presentation and interpretation stem in part from an inadequate understanding of the roles of moderators and mediators of treatment outcome. As a result, 1) the results of clinical research are slow to have an impact on clinical decision making and thus to benefit patients; 2) it is difficult for clinicians or patients to apply randomized clinical trial results comparing two treatments (treatment versus control); 3) when such trials are conducted at various sites, the results often do not replicate; 4) when the results influence clinical decision making, the results clinicians obtain do not match what researchers report; and 5) the treatment effects comparing treatment and control conditions, particularly for psychiatric treatments, often seem trivial. In this review article, the author reviews and integrates the methodological literature concerning dealing with covariates in trials to emphasize their impact on clinical decision making. The goal of trials should ultimately be to establish who should get the treatment condition rather than the control condition (moderators) and to determine how to obtain the best outcomes with whatever is the preferred treatment (mediators). The author makes recommendations to clinicians as to which trials might best be ignored and which carefully considered, and urges clinical researchers to focus on studies best designed to reduce the burden of mental illness on patients.
引用
收藏
页码:672 / 679
页数:8
相关论文
共 50 条
  • [41] Contributions of randomized clinical outcome trials to a major cardiology meeting
    Wang, Tom Kai Ming
    Stewart, Ralph
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 931 - 932
  • [42] In search of mechanisms of change in treatment outcome research: Mediators and moderators of psychological and pharmacological treatments for irritable bowel syndrome
    Labus, Jennifer S.
    [J]. GASTROENTEROLOGY, 2007, 133 (02) : 702 - 705
  • [43] Efficacy, moderators and mediators in the treatment of children with aggressive behavior problems
    Doepfner, Manfred
    Goertz-Dorten, Anja
    Hasselbeck, Hendrik
    Hautmann, Christopher
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S17 - S18
  • [44] Moderators and mediators of outcome in Internet-based indicated prevention for eating disorders
    Voelker, Ulrike
    Jacobi, Corinna
    Trockel, Mickey T.
    Taylor, C. Barr
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 2014, 63 : 114 - 121
  • [45] Seizure freedom as an outcome in epilepsy treatment clinical trials
    Halford, Jonathan J.
    Edwards, Jonathan C.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2020, 142 (02): : 91 - 107
  • [46] Monitoring of Treatment Outcome in Clinical Trials and in Routine Practice
    Grapsa, Dimitra
    Syrigos, Kostas
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S170 - S172
  • [47] Technologies for Automating Randomized Treatment Assignment in Clinical Trials
    Uwe Haag
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (1): : 7 - 11
  • [48] Fragility of randomized clinical trials of treatment of clavicular fractures
    Ruzbarsky, Joseph J.
    Khormaee, Sariah
    Rauck, Ryan C.
    Warren, Russell F.
    [J]. JOURNAL OF SHOULDER AND ELBOW SURGERY, 2019, 28 (03) : 415 - 422
  • [49] THE CASE FOR RANDOMIZED CLINICAL-TRIALS ON THE TREATMENT OF OBESITY
    STERN, MP
    [J]. OBESITY RESEARCH, 1995, 3 : S299 - S306
  • [50] Technologies for automating randomized treatment assignment in clinical trials
    Haag, U
    [J]. DRUG INFORMATION JOURNAL, 1998, 32 (01): : 7 - 11